Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

6(100.0%)

6Total

N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07443124Not ApplicableNot Yet Recruiting

Simeox 200 US Study

Role: lead

NCT06555484Not ApplicableCompleted

Acute Effects of Supplemental Oxygen on Memory Testing in Healthy Adult Volunteers

Role: lead

NCT06000332Not ApplicableCompleted

Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia

Role: lead

NCT05719363Not ApplicableCompleted

Portable Oxygen Concentrator in Non-hospitalized Patients With Chronic Heart Failure

Role: lead

NCT05212831Not ApplicableCompleted

Portable Oxygen Concentrator (POC) Versus Standard of Care in Long-COVID: Randomized Crossover Exploratory Pilot Study.

Role: lead

NCT03513068Not ApplicableTerminated

Portable Oxygen Concentrator Improvements to Physical Activity, Oxygen Usage, and Quality of Life in Chronic Obstructive Pulmonary Disease Patients Using Long-term Oxygen Therapy (POC-STEP)

Role: collaborator

All 6 trials loaded